Cite
HARVARD Citation
Gardner, S. et al. (n.d.). A Double‐blind, randomized, placebo‐controlled study to assess the safety, antiviral activity and pharmacokinetics of GSK2336805 when given as monotherapy and in combination with peginterferon alfa‐2a and ribavirin in hepatitis C virus genotype 1‐infected treatment‐naive subjects. Liver international. pp. e89-e95. [Online].